Statement Of Cash Flows [Abstract]

Sopharma Trading AD - Filing #6022496

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
- BGN
- BGN
- BGN
- BGN
9 080 BGN
9 080 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
8 050 BGN
8 050 BGN
Interest paid, classified as operating activities
4 419 BGN
3 129 BGN
Other inflows (outflows) of cash, classified as operating activities
1 073 BGN
586,000 BGN
Cash flows from (used in) operating activities
18 580 BGN
172 859 BGN
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
1 371 BGN
841,000 BGN
Purchase of property, plant and equipment, classified as investing activities
5 738 BGN
7 528 BGN
Purchase of intangible assets, classified as investing activities
3 486 BGN
5 290 BGN
Cash advances and loans made to other parties, classified as investing activities
1 958 BGN
10,000 BGN
Cash flows from (used in) investing activities
12 149 BGN
14 325 BGN
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
15 064 BGN
14 708 BGN
Interest paid, classified as financing activities
294,000 BGN
428,000 BGN
Cash flows from (used in) financing activities
11 287 BGN
191 752 BGN
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
4 856 BGN
4 568 BGN
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
4,000 BGN
- BGN
Cash and cash equivalents
6 833 BGN
11 694 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.